Basic Information
LISDEXAMFETAMINE DIMESYLATE
43602-308
Regulatory Information
43602-308
ANDA217442
C73584
August 28, 2023
USA
These highlights do not include all the information needed to use LISDEXAMFETAMINE DIMESYLATE CAPSULES safely and effectively. See full prescribing information for LISDEXAMFETAMINE DIMESYLATE CAPSULES. LISDEXAMFETAMINE DIMESYLATE capsules, for oral use, CII Initial U.S. Approval: 2007
HUMAN PRESCRIPTION DRUG LABEL
1
Company Information
080938961
Active Ingredients
MICROCRYSTALLINE CELLULOSE
Code: OP1R32D61U
Class Code: IACT
CROSCARMELLOSE SODIUM
Code: M28OL1HH48
Class Code: IACT
MAGNESIUM STEARATE
Code: 70097M6I30
Class Code: IACT
GELATIN
Code: 2G86QN327L
Class Code: IACT
SODIUM LAURYL SULFATE
Code: 368GB5141J
Class Code: IACT
SHELLAC
Code: 46N107B71O
Class Code: IACT
PROPYLENE GLYCOL
Code: 6DC9Q167V3
Class Code: IACT
AMMONIA
Code: 5138Q19F1X
Class Code: IACT
FERROSOFERRIC OXIDE
Code: XM0M87F357
Class Code: IACT
POTASSIUM HYDROXIDE
Code: WZH3C48M4T
Class Code: IACT
FD&C RED NO. 3
Code: PN2ZH5LOQY
Class Code: IACT
FD&C YELLOW NO. 6
Code: H77VEI93A8
Class Code: IACT
TITANIUM DIOXIDE
Code: 15FIX9V2JP
Class Code: IACT
Active Moieties
LISDEXAMFETAMINE
Code: H645GUL8KJ